Breast cancer screening: know your lifetime risk early
Mammograms catch only 75% to 85% of breast cancers, and because more than half of women over 40 have dense breast tissue that hides tumors in a white background, a gynecologist who was diagnosed after a negative mammogram, ultrasound and MRI says your calculated lifetime risk, not your family history, should decide when you start imaging.
- What to do: Calculate your lifetime risk with the Tyrer-Cuzick tool using age, height, weight, breast density, family history, age at first period and menopause, and biopsy results. If it is 20% or more, start imaging as early as age 30.
- Why it matters: One in eight women, or 12.5%, develops breast cancer, and 85% have no family history. The guest had no family history or mutation, yet an atypia biopsy pushed the lifetime risk to 37%, and an invasive cancer was later found.
- How to apply it: With dense breasts, ask for a 3D mammogram and a breast ultrasound. Above 20% to 25% risk, add an annual breast MRI. Ask your doctor for genetic cancer testing by age 25, and about hormone therapy only after individual risk review.
- Metrics: Alcohol at one glass a day raised breast cancer risk by about 40% in a JAMA study cited, and polygenic risk scores above the 90th percentile flag higher risk. Useful labs include A1C, ApoB, lipoprotein(a), hs-CRP, homocysteine, vitamin D, B12 and ferritin.
- Tools: 3D mammography, breast ultrasound, breast MRI, genetic panels, the Galleri multi-cancer blood test and Function Health lab panels.
- Risks: No blood test can tell you whether you will get breast cancer. Estrogen-driven risk rises with obesity, alcohol, inactivity, xenoestrogens and an unhealthy microbiome.
- Exceptions: After an estrogen receptor positive cancer, hormone therapy is not started casually, and tamoxifen cannot be combined with hormone replacement.